We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+3.73%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$196M
AUM Growth
+$16.9M
Cap. Flow
+$11.5M
Cap. Flow %
5.88%
Top 10 Hldgs %
45.53%
Holding
92
New
22
Increased
23
Reduced
22
Closed
6

Top Buys

Rank Stock Value
1
TPB icon
Turning Point Brands
TPB
+$3.38M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$1.73M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.45M
4
IBB icon
iShares Biotechnology ETF
IBB
+$1.36M
5
SLV icon
iShares Silver Trust
SLV
+$1.14M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.53M
2
AMD icon
Advanced Micro Devices
AMD
+$1.49M
3
GLD icon
SPDR Gold Trust
GLD
+$1.17M
4
TBHC
The Brand House Collective
TBHC
+$954K
5
LOW icon
Lowe's Companies
LOW
+$770K

Sector Composition

Rank Sector Weight
1 Healthcare 35.09%
2 Technology 12.85%
3 Communication Services 9.63%
4 Financials 3.93%
5 Consumer Staples 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$15.1M 7.71%
45,000
+10,000
+29% +$3.31M
GLD icon
2
SPDR Gold Trust
GLD
$131B
$11.2M 5.75%
63,500
-6,500
-9% -$1.17M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.36T
$11.2M 5.71%
152,000
+19,000
+14% +$1.45M
ITCI
4
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$11M 5.6%
427,000
+1,500
+0.4% +$34.2K
XNCR icon
5
Xencor
XNCR
$1.5B
$7.31M 3.74%
188,500
-1,867
-1% -$64.9K
QQQ icon
6
PUT
Invesco QQQ Trust
QQQ
$453B
$7.22M 3.69%
26,000
-24,000
-48% -$6.51M
MU icon
7
Micron Technology
MU
$930B
$7.21M 3.69%
153,500
-4,000
-3% -$194K
REGN icon
8
Regeneron Pharmaceuticals
REGN
$78.5B
$6.94M 3.55%
12,400
– –
ARGX icon
9
argenx
ARGX
$53.4B
$6.3M 3.22%
24,000
– –
ABBV icon
10
AbbVie
ABBV
$443B
$5.61M 2.87%
64,000
+4,850
+8% +$457K
INCY icon
11
Incyte
INCY
$24.2B
$5.38M 2.75%
60,000
+1,500
+3% +$145K
ORCL icon
12
Oracle
ORCL
$374B
$5.08M 2.6%
85,000
– –
GLD icon
13
CALL
SPDR Gold Trust
GLD
$131B
$5.05M 2.58%
28,500
+16,000
+128% +$2.88M
AMD icon
14
Advanced Micro Devices
AMD
$776B
$4.51M 2.31%
55,000
-20,000
-27% -$1.49M
GDX icon
15
VanEck Gold Miners ETF
GDX
$22.7B
$4.31M 2.2%
110,000
+42,500
+63% +$1.73M
BAC icon
16
Bank of America
BAC
$435B
$4.04M 2.06%
167,500
– –
ALNY icon
17
Alnylam Pharmaceuticals
ALNY
$27.5B
$4M 2.05%
27,500
– –
T icon
18
AT&T
T
$159B
$3.85M 1.97%
178,740
+13,240
+8% +$296K
VZ icon
19
Verizon
VZ
$195B
$3.81M 1.95%
64,000
+6,500
+11% +$378K
IAU icon
20
iShares Gold Trust
IAU
$62.9B
$3.6M 1.84%
100,000
– –
TPB icon
21
Turning Point Brands
TPB
$1.45B
$3.48M 1.78%
124,750
+115,000
+1,179% +$3.38M
FMS icon
22
Fresenius Medical Care
FMS
$13.8B
$3.08M 1.57%
72,500
+6,000
+9% +$259K
GDXJ icon
23
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$3.04M 1.56%
55,000
+12,500
+29% +$720K
AMGN icon
24
Amgen
AMGN
$208B
$2.86M 1.46%
11,250
-500
-4% -$124K
C icon
25
Citigroup
C
$222B
$2.8M 1.43%
65,000
– –
1
2 3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, DCF Advisers held 92 positions worth $196M, up 9.4% from $179M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

DCF Advisers deployed $11.5M of net new capital in Q3 2020, opening 22 new positions and adding to 23 existing holdings. Its largest new stake was iShares Biotechnology ETF: 10,000 shares worth $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $1.53M trimmed.

  • DCF Advisers's largest Q3 2020 buy was iShares Biotechnology ETF: 10,000 shares worth $1.35M.
  • DCF Advisers added most to Turning Point Brands in Q3 2020, an estimated $3.38M increase.
  • DCF Advisers's biggest Q3 2020 reduction was Berkshire Hathaway Class B, cutting an estimated $1.53M.
  • DCF Advisers's ten largest holdings make up 46% of its $196M portfolio in Q3 2020.
  • DCF Advisers opened 22 new positions and closed 6 in Q3 2020.
  • DCF Advisers's portfolio value rose 9.4% quarter-over-quarter to $196M.

Based on DCF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.